CompletedPhase 2

Lidocaine in ERAS for FESS

Egypt43 participantsStarted 2017-02-09

Plain-language summary

Functional endoscopic sinus surgery (FESS) is a commonly performed procedure. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients, 20-50 yr ASA class I and II * Elective Functional endoscopic sinus surgery (FESS) under general anesthesia. Exclusion Criteria: * Patient refusal, allergy to the study medication, pre-existing chronic pain at any site requiring treatment, intolerance to nonsteroidal anti-inflammatory drugs (NSAIDs), psychiatric or neurological disorders, seizure disorder requiring medication within the previous 2 years, body mass index \> 30 kg/ m2, revision sinus surgery, pregnancy, and patients with cardiovascular, cerebrovascular, respiratory, renal or hepatic diseases

What they're measuring

Intraoperative bleeding

Timeframe: Intraoperative assessment till end of operation

Trial details

NCT IDNCT03047070

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Intraoperative Bleeding trials